MSB 3.21% $1.13 mesoblast limited

Ann: Trading Halt, page-88

  1. 1,055 Posts.
    lightbulb Created with Sketch. 1116
    MSB has often softened the blow of bad news by issuing trading halts and in carefully worded press releases. The two main reasons I ended up selling out were transparency of corporate communications and cash burn.

    I think we're in for a couple more years of this before they can get close to another successful phase 3 and approval. Novartis deal going through would be a nice catalyst though for the share price in the short term as it would provide a bit of a remedy to both of those issues.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.